Guide
Tirzepatide: A Research Compound Overview
Tirzepatide is a synthetic peptide engineered to act at two incretin receptors at once. This overview covers what it is, the receptor pharmacology researchers study, where it sits among incretin analogues, and why batch-level purity matters. It is written for laboratory research context only and makes no human-use claims.
What tirzepatide is
Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It carries CAS number 2023788-19-2, the molecular formula C225H348N48O68, and a molecular weight of 4813.52 g/mol.
It is supplied as a lyophilized powder, double-purified by high-performance liquid chromatography.
Why it is studied
In laboratory research tirzepatide is used as a reference material in GIP and GLP-1 receptor-binding and activation assays. The dual-receptor profile is the reason it is characterised alongside single-receptor analogues rather than on its own.
It also appears in incretin-signaling pathway research in cell models, in comparative peptide-analog characterisation, and in analytical method development. No medical, therapeutic, or diagnostic claims are made.
Where it sits among incretin analogues
Incretin-receptor research compounds are often grouped by how many receptors they engage. Single-receptor analogues act at GLP-1 alone; tirzepatide adds the GIP receptor; retatrutide adds a third target at the glucagon receptor.
That progression is why these compounds are frequently characterised side by side in receptor-binding work. The comparison is one of structure and receptor targets only — no outcome of any kind is implied or claimed.
Handling and storage
Long-term storage is at -20°C (-4°F), kept desiccated and protected from UV. Original batch labeling is retained so the lot stays traceable for re-verification.
This overview does not cover preparation or use of any kind. That falls outside laboratory research reference use, and we do not provide that guidance.
How to verify a tirzepatide batch
Before relying on any batch, confirm three things: a purity percentage by HPLC, an identity confirmation with the analytical method named beside it, and a traceable lot number with a test date. The identity method is not always mass spectrometry — some lots are confirmed by FTIR — so read which technique the report actually names rather than assuming.
If the supplier lets you look up that batch’s report, you can match the documentation to the vial in hand. See our guide on how to read a peptide COA for a field-by-field walkthrough.